MARKET

DNPUF

DNPUF

DAI Nippon Pharm
OTCPK
11.60
NaN%
Closed 09:30 04/02 EDT
OPEN
--
PREV CLOSE
11.60
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
19.20
52 WEEK LOW
4.000
MARKET CAP
4.61B
P/E (TTM)
6.54
1D
5D
1M
3M
1Y
5Y
1D
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
TipRanks · 03/25 07:02
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
TipRanks · 03/06 00:22
Sumitomo Pharma Launches ‘Boost 2028’ Plan to Build on V-Shaped Recovery
TipRanks · 03/02 06:57
Sumitomo Pharma Lifts Full-Year Profit Outlook on Strong GEMTESA Sales and Weaker Yen
TipRanks · 03/02 06:57
Sumitomo Pharma Files ¥140 Billion Shelf Registration to Fund Growth and Bolster Finances
TipRanks · 03/02 06:57
Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived parkinson’s treatment
Seeking Alpha · 02/20 11:20
Sumitomo Pharma Posts Surging Profit and Higher Revenue in Q3 FY2025 Under IFRS
TipRanks · 01/30 07:13
Sumitomo Pharma Outlines Q3 FY2025 Results With Caution on Forward-Looking Data
TipRanks · 01/30 07:13
More
About DNPUF
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.

Webull offers Sumitomo Pharma Co Ltd stock information, including OTCPK: DNPUF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DNPUF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DNPUF stock methods without spending real money on the virtual paper trading platform.